PYTHARO Trademark
Trademark Overview
On Wednesday, October 21, 2015, a trademark application was filed for PYTHARO with the United States Patent and Trademark Office. The USPTO has given the PYTHARO trademark a serial number of 79180959. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, July 31, 2023. This trademark is owned by Novartis AG. The PYTHARO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
General Information
| Serial Number | 79180959 |
| Word Mark | PYTHARO |
| Filing Date | Wednesday, October 21, 2015 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Monday, July 31, 2023 |
| Registration Number | 4971227 |
| Registration Date | Tuesday, June 7, 2016 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 22, 2016 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Friday, February 16, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Thursday, January 21, 2016 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
| Friday, January 22, 2016 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, January 28, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 2, 2016 | APPLICATION FILING RECEIPT MAILED |
| Friday, February 5, 2016 | ASSIGNED TO EXAMINER |
| Friday, February 5, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 2, 2016 | NOTICE OF PUBLICATION |
| Tuesday, March 22, 2016 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 7, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, July 7, 2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Friday, July 8, 2016 | FINAL DISPOSITION PROCESSED |
| Friday, July 8, 2016 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, December 9, 2016 | NOTIFICATION PROCESSED BY IB |
| Friday, March 2, 2018 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, March 2, 2018 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, August 10, 2018 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Friday, August 23, 2019 | NOTIFICATION PROCESSED BY IB |
| Monday, August 21, 2023 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Monday, August 21, 2023 | DEATH OF INTERNATIONAL REGISTRATION |
| Monday, August 21, 2023 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Saturday, July 13, 2024 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Wednesday, December 10, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, December 10, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
